Found 69 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 3
Interventional
This study investigates chronic lung allograft dysfunction. It includes adult participants who have had a bilateral lung transplant.This study evaluates the effectiveness and safety of an investigational medication. It is compared with a placebo, and participants also receive standard treatments.Who can participate: Adults who are at least 18 years old …
18 years - 75 years
All genders
Phase 2
Interventional
This study evaluates the effectiveness and safety of an investigational medication for adults with ulcerative colitis.The study investigates the safety and effectiveness of different doses of the investigational medication. It focuses on understanding how well the medication works and how safe it is for participants.Who can participate: Adults aged 18 …
18 years or above
All genders
Phase 2
Interventional
This study investigates moderate to severe hidradenitis suppurativa. The purpose of this study is to assess the effects of an investigational medication on this condition.The study evaluates the safety and effectiveness of the investigational medication. Participants will be monitored to understand how well the investigational medication works for hidradenitis suppurativa.Who …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates how an investigational medication might work for people with ulcerative colitis.The purpose of this study is to evaluate the efficacy and safety of the investigational medication. It focuses on how well the medication works and how safe it is for participants.Who can participate: Participants aged 16 to …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates ulcerative colitis. Participants with moderately to severely active forms of this condition are involved in the research.The focus of this study is to evaluate the safety and effectiveness of an investigational medication in treating ulcerative colitis. The study will look at how well the medication works and …
18 years or above
All genders
Phase 2
Interventional
This study investigates moderate to severe hidradenitis suppurativa. The purpose of this study is to evaluate different doses of an investigational medication.The study focuses on assessing the safety and effectiveness of the investigational medication. It evaluates how well the medication works and how safe it is for participants.Who can participate: …
6 months - 17 years
All genders
Phase 3
Interventional
This study investigates prurigo nodularis in children and teens. The purpose of this study is to understand how the investigational medication is processed in the body and to evaluate its safety in participants with prurigo nodularis.The study evaluates the safety and how the body absorbs, distributes, and gets rid of …
50 years - 90 years
All genders
Phase 1/2
Interventional
This study investigates neovascular age-related macular degeneration. It looks at the safety and effectiveness of a one-time dose of an investigational medication given as an eye injection.The purpose of this study is to evaluate how safe the investigational medication is and how well it works for this condition. It checks …
6 months - 6 years
All genders
Phase 3
Interventional
This study investigates eosinophilic esophagitis in young children.The study evaluates the safety, tolerability, and effectiveness of an investigational medication in children with this condition.Who can participate: Children aged 6 months and weighing 5 kg to less than 15 kg with active eosinophilic esophagitis can participate. Participants must not have previously …
18 years - 80 years
All genders
Phase 2
Interventional
This study investigates non-cystic fibrosis bronchiectasis. It involves participants aged 18 to 80 years.The study evaluates the activity and safety of an investigational medication. It compares this medication with a placebo.Who can participate: Adults aged 18 to 80 years with a history of non-cystic fibrosis bronchiectasis can participate. Key factors …